Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2019-01-14 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOISSY-SOUS-SAINT-YON (91790), Essonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE DU GINKGO : revenue, balance sheet and financial ratios
SELURL PHARMACIE DU GINKGO is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOISSY-SOUS-SAINT-YON (91790),
this company of category PME
shows in 2024 a net income positive of 77 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE DU GINKGO (SIREN 844667212)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
76 742 €
75 877 €
47 744 €
114 843 €
100 729 €
188 357 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELURL PHARMACIE DU GINKGO generates positive net income of 77 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 188 k€ -> 77 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
76 742 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 127%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
127.337%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.8%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE DU GINKGO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
624.079
384.638
260.253
207.161
161.378
127.337
Financial autonomy
11.743
18.382
24.815
29.256
34.517
39.8
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
127.342024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-7 pts over 3 years
In 2024, the debt ratio of SELURL PHARMACIE DU GINKGO (127.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.8%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+12 pts over 3 years
In 2024, the financial autonomy of SELURL PHARMACIE DU GINKGO (39.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 172.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
172.823
Liquidity indicators evolution SELURL PHARMACIE DU GINKGO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
137.688
175.135
0.0
173.389
187.067
172.823
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
172.822024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+8 pts over 3 years
In 2024, the liquidity ratio of SELURL PHARMACIE DU GINKGO (172.82) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELURL PHARMACIE DU GINKGO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELURL PHARMACIE DU GINKGO is estimated at
1 071 375 €
(range 746 088€ - 1 602 838€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
746k€1071k€1602k€
1 071 375 €Range: 746 088€ - 1 602 838€
NAF 5 année 2024
Valuation method used
Net Income Multiple
76 742 €
×
14.0x
=1 071 375 €
Range: 746 089€ - 1 602 838€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE DU GINKGO with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE DU GINKGO
What is the revenue of SELURL PHARMACIE DU GINKGO ?
The revenue of SELURL PHARMACIE DU GINKGO is not publicly disclosed (confidential accounts filed with INPI).
Is SELURL PHARMACIE DU GINKGO profitable?
Yes, SELURL PHARMACIE DU GINKGO generated a net profit of 77 k€ in 2024.
Where is the headquarters of SELURL PHARMACIE DU GINKGO ?
The headquarters of SELURL PHARMACIE DU GINKGO is located in BOISSY-SOUS-SAINT-YON (91790), in the department Essonne.
Where to find the tax return of SELURL PHARMACIE DU GINKGO ?
The tax return of SELURL PHARMACIE DU GINKGO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE DU GINKGO operate?
SELURL PHARMACIE DU GINKGO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart